Download this publication
This Half Yearly Performance Snapshot provides statistical information for the period 1 July 2021 to 31 December 2021 in relation to our regulation of therapeutic goods, tracking our progress against some of the priorities outlined in the TGA Business Plan. This data will be incorporated into our Annual Performance Statistics Report for the 2021-22 financial year, to be published on the TGA website in the second half of 2022.
Contents
- About the Therapeutic Goods Administration
- Executive Summary
- Performance highlights
- Impacts of COVID-19
- Reforms and updates
- Recalls
- Processing and approval times
- Prescription medicines
- Over-the-Counter medicines
- Listed and Complementary medicine
- Biologicals and blood components
- Medical devices
- Listed Other Therapeutic Goods (Disinfectants)
- Exports
- Access to unapproved therapeutic goods
- Licensing and manufacturing
- Laboratory testing
- Medicine and vaccine adverse event reporting
- Medical device incident reports
- Regulatory compliance
- Recalls
- Pharmacovigilance Inspection Program
- Reporting of medicine shortages